Renzapride hydrochloride

Renzapride hydrochloride is a prokinetic agent mainly studied and used for Constipation-Predominant Irritable Bowel Syndrome (IBS-C), acting as a 5-HT4 agonist and 5-HT3 antagonist to speed up gut transit and relieve abdominal pain, improving bowel habits. It also shows promise for other gastrointestinal issues like diabetic gastroparesis (delayed stomach emptying) due to its ability to accelerate gastric emptying, making it a potential treatment for upper GI disorders as well. It is grouped under the following drug class(es): Prokinetic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include 4-Amino-N-(1-azabicyclo[3.3.1]nonan-4-yl)-5-chloro-2-methoxybenzamide and hydrochloride. Its PubChem CID is 20843171.

CAS No 109872-41-5
Molecular Formula C16H23Cl2N3O2
Molecular Weight 360.3 g/mol
Synonyms 4-amino-N-[(4R,5S)-1-azabicyclo[3.3.1]nonan-4-yl]-5-chloro-2-methoxybenzamide;hydrochloride

Frequently Asked Questions